Immunotherapy Recall: Chemoradiation-Induced Reactivation of Immune Checkpoint Inhibitor Nephritis

Affiliations

¹ Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
² Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
³ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
⁴ Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center at Houston, Houston, TX.
⁵ Section of Nephrology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

Julius Weng et al. JCO Precis Oncol. 2022 Aug.

. 2022 Aug:6:e2200049.

doi: 10.1200/PO.22.00049.

¹ Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
² Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
³ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
⁴ Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center at Houston, Houston, TX.
⁵ Section of Nephrology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

No abstract available

MeSH terms